Simple skin test could spot diabetes in pregnancy earlier
NCT ID NCT06048510
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing two new ways to predict gestational diabetes and large babies (macrosomia) in pregnant women. Researchers will measure skin autofluorescence and glycated albumin in 800 pregnant women and compare them to the standard HbA1c test. The goal is to see if these markers can catch problems earlier, before current screening at 24-28 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to earlier and simpler screening for gestational diabetes, helping prevent complications like large babies.
- What could go wrong
- This is an observational study, not a treatment trial. The new markers may not prove more accurate than current tests, and results may not change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS IN PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Pellegrin
RECRUITINGBordeaux, 33000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could earlier testing for pregnancy diabetes prevent complications?
- Pregnancy study seeks links between insulin resistance and placental problems
- Can a simple toolkit tame pregnancy diabetes and hypertension?
- Could your sleep and meal timing in early pregnancy predict diabetes?
- Can a First-Trimester blood test catch pregnancy diabetes sooner?
- Can a 24-Hour patch after delivery predict future diabetes?